Warren Alpert Medical School of Brown University, Providence, RI, USA.
University of Massachusetts Chan Medical School, Worcester, USA.
Perit Dial Int. 2023 Sep;43(5):361-373. doi: 10.1177/08968608221133629. Epub 2022 Nov 9.
The peritoneal equilibration test (PET), first described in 1987, is a semiquantitative assessment of peritoneal transfer characteristics in patients undergoing peritoneal dialysis. It is typically performed as a 4-h exchange using 2.27/2.5% dextrose dialysate with serial measurements of blood and dialysate creatinine, urea, and glucose concentrations. The percentage absorption of glucose and D/P creatinine ratio are used to determine peritoneal solute transfer rates. It is used to both help guide peritoneal dialysis prescriptions and to prognosticate. There are several derivative tests which have been described in the literature. In this review, we describe the original PET, the various iterations of the PET, the information gleaned, and the use in the setting of poor solute clearance and in the diagnosis of membrane dysfunction, and limitations of the PET.
腹膜平衡试验(PET)于 1987 年首次描述,是对腹膜透析患者腹膜转运特性的半定量评估。它通常使用 2.27%/2.5%葡萄糖透析液进行 4 小时交换,并对血和透析液中肌酐、尿素和葡萄糖浓度进行连续测量。葡萄糖的吸收率和 D/P 肌酐比用于确定腹膜溶质转运率。它既用于帮助指导腹膜透析处方,也用于预后判断。文献中已经描述了几种衍生试验。在这篇综述中,我们描述了原始的 PET、PET 的各种变体、获得的信息以及在溶质清除不良和膜功能障碍诊断中的应用,以及 PET 的局限性。